Weekly cannabis use linked to entry symptoms, not later Long COVID
Associations between substance use and symptomatic Long COVID in the Researching COVID to Enhance Recovery (RECOVER)-adult cohort study.
AI Summary
This prospective cohort study examined whether tobacco, cannabis, and binge alcohol use in the year before SARS-CoV-2 infection was associated with symptomatic Long COVID. It included 9,477 adults across 83 U.S. clinical sites and assessed both symptoms at study entry and new symptomatic Long COVID over 12 months among participants who did not have it at entry.
At study entry, weekly or more cannabis use was associated with higher odds of symptomatic Long COVID than no use (adjusted odds ratio 1.23; 95% CI 1.00–1.52), while monthly or less cannabis use was not associated. Cannabis use was not statistically significantly associated with developing symptomatic Long COVID during follow-up. Weekly or more tobacco use was associated with higher odds at entry and during follow-up; weekly or more binge alcohol use was associated with lower odds at entry but not at follow-up. These are observational associations, not evidence that substance use caused or prevented symptoms. This abstract-based summary cannot establish causation, and it does not show that the reported associations represent clinically meaningful effects.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Brain blood-flow reductions in acute anorexia follow a cortical hierarchy
CBD showed limited adaptive-functioning differences versus placebo in boys…
Resilience linked to depression outcomes and THC positivity
Explore More Research
Stay informed about the latest cannabis science.